Source:http://linkedlifedata.com/resource/pubmed/id/16105159
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2005-8-17
|
pubmed:abstractText |
We compared a third generation quantitative cardiac troponin T (cTnT) point-of-care testing (POCT) from Roche Diagnostics with the laboratory assay (Roche Elecsys 2010 immunoassay analyser). Heparin-treated blood and serum were collected simultaneously in 133 unselected patients (mean age 62 +/- 14 years, 38% females) presenting to our hospital with possible cardiac chest pain. Results of the POCT were measured against the laboratory-based assay considered as the gold standard. There were 18 POCT positive versus 24 laboratory assay positive (> or = 0.03 ng/mL) patients. POCT was falsely negative in six patients, with values between 0.03 and 0.1 ng/mL. The POCT had a sensitivity of 75%, specificity of 100%, positive predictive value of 100%, negative predictive value of 95% and a total accuracy of 95%; kappa = 0.831 (P < 0.001). There was good correlation between the values of POCT and the laboratory assay: Y = 1.195X + 0.002, r2 = 0.94 (P < 0.0001). Whereas cTnT levels > 0.1 mg/mL were reliably detected with this current generation of POCT, cTnT levels between 0.03 and 0.10 ng/mL were not. Future generations of devices will need to improve sensitivity to reliably risk stratify patients with suspected acute coronary syndromes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1444-0903
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
560-2
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16105159-Acute Disease,
pubmed-meshheading:16105159-Biological Markers,
pubmed-meshheading:16105159-Coronary Disease,
pubmed-meshheading:16105159-Humans,
pubmed-meshheading:16105159-Immunoassay,
pubmed-meshheading:16105159-Middle Aged,
pubmed-meshheading:16105159-Point-of-Care Systems,
pubmed-meshheading:16105159-Predictive Value of Tests,
pubmed-meshheading:16105159-Prognosis,
pubmed-meshheading:16105159-Retrospective Studies,
pubmed-meshheading:16105159-Severity of Illness Index,
pubmed-meshheading:16105159-Troponin T
|
pubmed:year |
2005
|
pubmed:articleTitle |
Use of a quantitative point-of-care test for the detection of serum cardiac troponin T in patients with suspected acute coronary syndromes.
|
pubmed:affiliation |
Department of Cardiology, Liverpool Hospital, Sydney, New South Wales, Australia. hallanhi@wahs.nsw.gov.au
|
pubmed:publicationType |
Journal Article,
Comparative Study
|